|
Mainland D. Some statistical problems in the planning and performance of clinical trials // Animal and Clinical Pharmacologic Techniques in Drug Evaluation / Eds. J. H. Nodine, P. E. Siegler. Chicago: Year Book Medical Publishers, 1964. P. 27-35.
Malsto S. A., Conners G. J., Sachs P. R. Expectation as a mediator in alcohol intoxication // Cognitive Therapy and Res. 1981. V. 5. P. 1-18.
Malitz S. Variables and Drug Effectiveness // Specific and Non-Specific Factors in Psychopharmacology / Ed. M. Rinkel. N. Y.: Philosophical Library, 1963. P. 141-148.
Mancia G. et al. Lack of placebo effect on ambulatory blood pressure // Amer. J. of Hypertension. 1995. V. 8. No. 3. P. 311-315.
Mann J. How medication compliance affects outcome // Psychiatric annals. 1986. V. 16. P. 537-570.
Mariani L., Ventresca G. P. II placebo e ancora eticamente accetabile e sci-entificamente utile nella sperimentazione clinica dei faramci? // Clini-ca Terapeutica. 1996. V. 147. N. 11. P. 595-598.
Литература 217
Me Clenon J. Spiritual healing and folklore research: evaluating the hypnosis/placebo theory // Altern. Ther. Health. 1997. V. 3. P. 61-66.
Meister W., Niebel J. Missbrauch und internistische Indikationen der Pla-cebotherapie. Das Placebo-Problem / Ed. H. Hippius. et al. Stuttgart; N. Y.: Fischer Verlag, 1986. S. 127-?
Mellergard M., Rosenberg N. K. Patterns of response during treatment of panic disorder // Acta Psychiatrica Scandinavica. 1990. V. 81. No. 4. P. 340-344.
Mendels J., Schless A. P. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients // J. Clin. Psychiatry. 1986. V. 47. P. 357-361.
Millar T. P. Humor: the triumph of reason // Perspectives in Biology and Medicine. 1986. V. 29. P. 545-559.
Mintz I. A note on the addictive personality: addiction to placebos // Amer. J. Psychiatry. 1977. V. 134. No. 3. P. 327-328.
Modell W., Garrett M. Interactions between pharmacodynamic and placebo effects in drug evaluation in man // Nature. 1960. V. 185. P. 538-539.
Mohr D. C, Goodkin D. E., Gatto V. et al. Depression, coping and level of neurological impairment in multiple sclerosis // Mult. Scler. 1997. V. 3. No. 4. P. 254-258.
Montgomery C, Kirsch I. Mechanisms of placebo pain reduction: an empirical investigation // Psychological Science. 1996. V. 7. No. 3. P. 174-176.
Montgomery S. A., Rasmussen J. G. C, Tanghoi P. Placebo response to acute treatment predicts relapse over 24 weeks in major depression // Psy-chopharmacology Bull. 1994. V. 30. P. 79-80.
Moscucci M. et al. Blinding, unblinding, and the placebo effect: an analysis of patients' guesses of treatment assignment in a double-blind clinical trial // Clinical Pharmacology and Therapeutics 1987. V. 41. No. 3. P. 259-265.
Munjak D. J. et. al. Actual medication versus therapist guesses: in a blind study, how blind is blind? // J. of Clinical Psychopharmaeolo-gy 1989. V. 9. No. 2. P. 148-149.
Muntaner C, Caseella N. G., Kumor К. М. et al. Placebo responses to cocaine administration in humans: effects of prior administrations and verbal instructions // Psychopharmacology. 1989. V. 99. P. 282-286.
Naber D., Walther A., Kircher T. et al. Subjective effects of neuroleptics predict compliance // Prediction of neuroleptic treatment outcome in schizophrenia: Concepts and Methods / Ed. W. Gaebel, A. G. Awad. Wien: Springer, 1994. P. 85-98.
Nash E. H., Frank J. D., Imber S. D.. Stone A. R. Selected effects of inert medication on psychiatric outpatients // Amer. J. Psychother. 1964. V. 18. Suppl. 1. P. 33-48.
Newlin D. B. Conditioned compensatory response to alcohol placebo in humans // Psychopharmacology. 1986. V. 88. P. 247-251.
Newlin D. B. Offsrping of alcoholics have enhanced antagonistic placebo response // J. of Studies on Alcohol. 1985. V. 46. No. 6. P. 490-494.
Newlin D. B. Placebo responding in the same direction as alcohol in women // Alcoholism: Clinical and Experimental Research. 1989. V. 13. No. 1. P. 36-39.
Nodine J. H., Siegler P. B. (Eds.) Animal and clinical pharmacologic techniques in drug evaluation. Chicago: Year Book Medical Publishers, 1964. 660 p.
Nota Bene (Editorial) CNS Spectrum. 1997. V. 2. No. 9. P. 14-15.
Novak R. D., AuvllNovak S. E. Focus group evaluation of night nurse shiftwork difficulties and coping strategies // Cronobiology international. 1996. V. 13. No. 6. P. 457-464.
218
Плацебо и терапия
Oelzner S., Bransstadt A., Hoffmann A. Correlations between subjective compliance, objective compliance, and factors determinig compliance in geriatric hypertensive patients treated with triamterene and hy-droclorothiazide. // Int. J. of Clinical Pharmacology and Therapeutics. 1996. V. 34. P. 236-242. Цит. по: РЖ Биология. 1997. No. 11. 97.11.04. Т. 1.6.
Oh V. M. The placebo effect: can we use it better? (Editorial) // Brit. Med. J., 1994. V. 309. No. 6947. P. 69-70.
Orr R. D. Guidelines for the use of placebo controls in clinical trials of pscyhopharmacologic agents // Psychiatr. Ser. 1996. V. 47. P. 1262-1264.
Oxenkrug G. F. Psychopharmacology behind the iron curtain // The Rise of Psychopharmacology and the Story of CINP / Ed. T. A. Ban, D. Healy, E. Shorter. Budapest: Animula, 1998. P. 330-334.
Oxtoby A., Jones A., Robinson M. Is your «double-blind» design truly double-blind? // Brit. J. Psychiatry. 1989. V. 155. P. 700-701.
Pancheri L. et al. II placebo come farmaco. Parte 2. II trattamento della depressione // Rev. Psichiat. 1991. V. 26. N. 1. P. 1-11. Цит. по: РЖ 04 Биология. 1991. 10.80.87.
Paran E. et al. Effect of placebo on office and on 24 hour noninvasive ambulatory blood pressure // J. of Human Hypertension. 1993. V. 7. No. 6. P. 567-570.
Past prescribing: An 18th century medical student worries about placebos // Brit. Med. J. 1996. V. 312. No. 7034. March 30. P. 837.
Реек С L., King N. J. Increasing patient compliance with prescription // JAMA. 1982. V. 248. P. 2874-2878.
Piercy M. A. et al. Placebo response in anxiety disorders // Ann. Pharma-cother. 1996. V. 30. P. 1013-1019.
Pigeau R., Naitoh P., Buguet A, McCann C. Modafanil, d-amphetamine and placebo during 64 hours of sustained mental work. 1. Effects on mood, fatigue, cognitive performance and body temperature // J. of Sleep Res. 1995. V. 4. No. 4. P. 212-228.
Plevova J., Bolelouchy Z., Bastecky Z. Placebo reaction in neurotics rated with the SCL-90 questionnaire // Activitas Nerv. Super. (Praha). 1979. V. 21. N. 3. P. 150-151.
Plevova J., Bolelouchy Z., Bastecky J. Anxiety and placebo reaction in neurotic patients // Agressologie. 1981. V. 22. P. 31-32.
Pogge R. The toxic placebo // Medical Times. 1963. V. 91. P. 773-778.
Poldinger W. Principal aspects of the use of placebos // Pharmacopsychi-at. 1976. V. 9. P. 302-304.
Praag van H. M. Tablets and talking — A spurious contrast in psychiatry // Comprehensive psychiatry. 1979. V. 6. P. 502-510.
Prien R. F. Mehtods and models for placebo use in pharmacotherapeutic trials // Pscyhopharmacol. Bull. 1988. V. 7 24. P. 4-8.
Priest R. G., Baldwin D. Depression and anxiety. London: Martin Dunitz. 1994. 82 p.
Prioleau L., Murdock M., Brody N. An analysis of psychotherapy versus placebo studies // The Behavioral and Brain Sciences. 1983. V. 6. P. 275-310.
Quit kin F. M. et al. Heterogeneity of clinical response during placebo treatment // Amer. J. Psychiatry 1991. V. 148. No. 2. P. 193-196 (cm. Quitkin, 1991a).
Quitkin F. M. et al. Different types of placebo response in patients receiving antidepressants // Amer. J. Psychiatry. 1991. V. 148. No. 2. P. 197-203 (cm. Quitkin, 19916).
Quitkin F. et al. Further evidence that a placebo response to antidepressants can be identified // Amer. J. Psychiatry. 1993. V. 150. P. 566-570.
Rabkin J. Placebo response in mild depression // Nursing Times. 1991. V. 87. No. 30. P. 54-55.
Литература 219
Rabkin J. G. et al. How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine // Psychiatry Research. 1986. V. 19. No. 1. P. 75-86. Ramamurti P. V. Coping with aging // Indian J. Med. Res. 1997. V. 106. P. 376-380.
Reich J. The effect of personality on placebo response in panic patients // J. Nervous and Mental Disease. 1990. V. 178. No. 11. P. 699-702.
Reilly D. T. et al. Is homoeopathy a placebo response? Controlled trial of homoeopathic potency with pollen in hayfever as model // Lancet. II. 1986. P. 881-885.
Rickels K. Use of placebo in clinical trials // Psychopharmacology Bull. 1986. V. 22. P. 19-24.
Rickels K., Hesbacher P. Т., Weise С. С et al Pills and improvement: A study of placebo response in psychoneurotic outpatients // Psychopharmaco-logia. 1970. V. 16. P. 318-328.
Rickels K., Lipman R. S., Park L. С et al. Drug, doctor warmth, and clinic setting in the symptomatic response to minor tranquillizers // Psy-chopharmacologia. 1971.
Rinkel M. (ed.) Specific and Non-Specific Factors in Psychopharmacology. N. Y.: Philosophical Library, 1963. 174 p.
Rosenberg M. J., Burnhill M. S., Waugh M. S. et al. Compliance and oral contraceptives: A review // Contraception. 1995. V. 52. P. 137-142.
Rosenberg M. K. et al. Characteristics of panic disorder patients responding to placebo // Acts Psychiatrica Scand. (Suppl.) 1991. V. 365. P. 33-38.
Rosental D., Frank J. D. Psychotherapy and the placebo effect // Psychol. Bull. 1956. V. 53. P. 294-301.
Rosenthal N. E., Sack D. A., Skewrer R. G. et al. Phototherapy for seasonal affective disorder // J. Biol. Rhythms. 1988. V. 3. P. 101-120.
Rotheram E. B. Placebo response in patients complaining of chrohic fatigue // Amer. J. of Medicine. 1991. V. 90 No. 6. P. 768-769.
Rounsaville B. J., Klerman G. L., Weissman M. M. Do psychotherapy and pharmacotherapy for depression conflict? Empirical evidence from a clinical trial // Arch. Gen. Psychiatry. 1981. V. 38. P. 24-29.
Rozin P., Reff D., Mark M., Schull J. Conditioned opponent responses in human tolerance to caffeine // Bull. Psychonom. Soc. 1984. V. 22. P. 117-120.
Rush A. J., Prien R. F. From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged? // Psychopharmacology Bull. 1995. V. 31. P. 7-20.
Rzepinska Maria. Historia koloru w dziejach malarstwa europejskiego. Krakow: Wydanictwo literackie, 1983. 644 s.
Summons J. H. Written instructions and patient compliance // JAMA. 1982.V. 248. No. 21. P. 2890.
Samson E. Rechtliche Aspekte von Placebo-Studien. «Das Placebo-Problem» / Herausgegebenen H. Hippius. et al. Stuttgart; N. Y.: Fisher Verlag, 1986. S. 2-10.
Sanchez L. E., Armanteros J. L., Small A. M. et al. Placebo response in aggressive children with conduct disorder // Psychopharmacol. Bull. 1994. V. 30. P. 126.
Sarles #., Cammate R., Sahel J. A study of the variations in the response regarding duodenal ulcer when treated with placebo by different investigators // Digestion. 1977. V. 16. No. 4. P. 289-292.
Saupe R. Der Placebo-Effekt. Eine Studie aus der Sicht von Arzten und Pflegepersonal // Mbnch. Med. Wschr. 1985. Bd. 127. Nr. 49. S. 1131-1133.
Saupe R. The use of placebo as seen by nursing staff // Pharmacopsychia-try. 1986. V. 19. No. 4. P. 3476-348.
220
Плацебо и терапия
Scheurer U. et al. Gaster und duodenal ulcer healing under placebo treatment // Gastroenterology. 1977. V. 77. P. 838.
Schindel L. Placebo und Placebo-Effekte in Klinik und Forschung // Arzne-imittelforschung. 1967. Bd. 17. S. 892.
Schoemaker P. G. W. Benefits of placebos // Nature. 1995. V. 377. No. 6545. P. 98.
Schooler N. R., Prien R. F. Placebos in psychopharmacology clinical trials: scientific and ethical issues // Psychopharmacology Bull. 1988. V. 24. P. 3-23.
Schweizer E., Rickets K. Placebo response in generalized anxiety: its effect on the outcome of clinical trials // J. Clin. Psychiatry. 1997. V. 58. Suppl. 11. P. 30-39.
Scott E. M. Humor and the alcoholic patient: a beginning study // Alcoholism Treatment Quaterly. 1989. V. 6. No. 2. P. 29-39.
Sellers E. M., Naranjo C. A. New strategies for the treatment of alcohol withdrawal syndrome // Psychopharmacol. Bull. 1986. V. 22. No. 1. P. 88-92.
Shapiro A. A contribution to a history of the placebo effect // Behavioral Science. 1960. V. 5. No. 2. P. 109-135.
Shapiro A. Placebogenesis and iatroplacebogenesis // Medical Times. 1964. V. 92. P. 1037-1047.
Schapiro A. Iatroplacebogenesis. Int. // Pharmacopsychiatry. 1969. V. 2. P. 215.
Schapiro A. Study of the effect of tablet color in the treatment of anxiety states // Brit. Med. J. 1970. V. 2. P. 446.
Shapiro A. Psychochemotherapy // Biological Foundations of Psychiatry / Ed. R. G. Grenell, S. Gabay. N. Y.: Raven Press, 1976. P. 793-835.
Shapiro A. The placebo effect. Principles of Psychopharmacology. N. Y.: Academic Press, 1978. P. 441-459.
Shapiro A., Morris L. A. The placebo effect in medical and psychological therapies. Handbook of psychotherapy and behavior change: an empirical analysis / Eds. S. L. Garfield, A. E. Bergin. 2nd edition. N. Y.: Wiley, 1978. P. 7-18.
Shapiro A., Struening E. A. A comparison of the attitudes of a sample of physicians about the effectiveness of their treatment and the treatem-nt of the other physicians // J. Psychiatr. Research. 1974. V. 10. P. 217-229.
Shapiro P. A. et al. Compliance complications in cardiac patients // Amer. J. Psychiatry. 1997. V. 154. No. 11. P. 1627-1628.
Shear M. K. et al. Pattern of placebo response in manic disorder // Psychopharmacol. Bull. 1995. V. 31. No. 2. P. 273-278.
Shimizu N.. Naito С Placebo side effects. // Clin. Pharmacol, and Ther. 1991. V. 49. No. 2. P. 154.
Sierra J. C, Carrasco T. J., Buela Casal G. Daytime sequelae of placebo use as a hypnotic in healthy volunteers // Ned. Sci. Research. 1995. V. 23. No. 10. P. 683-684.
Silber T. J. Placebo therapy. The ethical dimension // JAMA. 1979. V. 242. P. 245-246.
Silvis S. E. The placebo in modern medicine (Editorial) // Gastrointest. Endosc. 1996. V. 43. P. 76-79.
Sperry L. Psychopharmacology and psychotherapy. Strategies for maximizing treatment outcomes. N. Y.: Brunner/Mazel., 1994. 194 p.
Stanley B. An integration of ethical and clinical considerations in the use of placebos // Psychopharmacol. Bull. 1988. V. 24. P. 18-20.
Steimer Т., Driscoll P., Schulz P. E. Metabolism of progesterone, coping behavior and emotional reactivity in male rats from two psychogenet-ically selected lines // J. of Neuroendocrinology. 1997. V. 9. No. 3. P. 169-176.
Sternbach R. A. Pain: A psychological analysis. N. Y.: Academic Press. 1968.
Литература
221
Stewart А. М„ Hopkins W. G. Swimmer's compliance with training prescription // Medicine and Science in Sports and Exercise. 1997. V. 29. No. 10. P. 1389-1393.
Stier S. The «splitted psychiatrist»: The «Biological» vs. the «Psycho-social» professional approach and attributional roles of the psychiatrist in the treatment of psychotic patients // The Synthesis between Peychopharmacology and Psychotherapy. Abstracts of the WPA Thematic Conference (Jerusalem, Israel, Nov. 16-21, 1997). P. 62.
Strasser T. Der Displacebo // Munch. Med. Wschr. 1964. Bd. 106. S. 2289-2293.
Straus J. L., Amman von C. S. Placebo effects: Issues for clinical practice in psychiatry and medicine // Psychosomatics. 1996. V. 37. P. 315-326.
Strauss W. H., Klieser E. Combination of pharmaco- and psychotherapy in the treatment of panic disorder // The Synthesis between Psychophar-macology and Psychotherapy. Abstracts of the WPA Thematic Conference (Jerusalem, Israel, Nov. 16-21, 1997). P. 62.
Stubhaug A., Grimstad J., Breivik H. Lack of analgesic effect of 50 and 100 mg oral tramadol after orthopaedic surgery: a randomized, double-blind placebo and standard active drug comparison // Pain. 1995. V. 62. No. 1. P. 111-119.
Sturdevant R. A. et al. Antacid and placebo produced similar pain relief in duodenal ulcer patients // Gastroenterology. 1977. V. 72. No. 1. P. 1-5.
Suetsugi M., Mizuki Y., Yamada M. Effect of placebo on nocturnal sleep in healthy voulnteers // Comparison with the drug free group. Abstracts of the X World Congress of Psychiatry (Madrid, August 23-28, 1996). 1996. V. 2. P. 81.
Taiminen Т., Syvalhti E., Saarijarvi S. et al. Is positive placebo response in chronic schizophrenia investigator-dependent? // J. Nerv. Ment. Disease. 1997. V. 185. P. 644-645.
Tanaka I., Koike K. (Eds.) Japanese Coloring 1982 // Therapie (Libro Port Co. Tokyo), 1996. V. 51. No. 6. P. 667-676.
Tangrea J. A. Patient participation and compliance in cancer chemopre-vention trials: issues and concerns // Proc. Soc. Exp. Biol. Med. 1997. V. 216. No. 2. P. 260-265.
Terman M., Terman J. S., Quitkin E. M. et al. Light therapy for seasonal affective disorder // Neuropsychopharmacol. 1989. V. 2. P. 1-21.
Thoma H., Kachele H. Psychoanalytic Practice. 2. Clinical Studies. Berlin; Heidelberg: Springer, 1992. 540 s.
Thor-Wiedermann S., Wiedermann G. Placebos? Uber die reproduzierbar nachweisbaren Wirkungen von Placebo // Deutsch. Med. Wschr. 1988. Bd. 113. S. 871-873.
Totman R. Cognitive dissonance in the placebo treatment of insomnia — a pilot experiment // Brit. J. of Med. Psychology. 1976. V. 49. No. 4. P. 393-400.
Tsuang M. 2\. Boor M., Fleming J. A. Psychiatric aspects of traffic accidents // Amer. J. Psychiatry. 1985. V. 142. P. 538-546.
Turner J. A. et al. The importance of placebo effects in pain treatment and research // JAMA. 1994. V. 271. No. 20. P. 1609-1614.
Туе L. Doctors' orders often disobeyed. Elderly found to neglect prescriptions // The Boston Globe. 1998, May 13. P. A12.
Van der Meer F. J. M. et al. The role of compliance as a cause of instability in oral anticoagulant therapy // Brit. J. Haematology. 1997. V. 98. No. 4. P. 893-900.
Vinar O. Dependence on a placebo. A case report // Brit. J. Psychiatr. 1969. V. 115. P. 1189.
Vogel A. V., Goodwin J. S., Goodwin J. M. The therapeutics of placebo // Amer. Family Physician. 1980. V. 22. No. 1. P. 105-109.
222
Плацебо и терапия
Wall M., Wheeler S. Benefits of the placebo effect in the therapeutic relationship // Complementary Therapeutics in Nursing and Midwifery 1996. V. 2. No. 6. P. 160-163.
Wardrope J. Bed shortage — hospitals need support for coping with emergency work // Brit. Med. J. 1997. V. 314. No. 7077. P. 369.
Weissman M. M. et al. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes // Amer. J. Psychiatry. 1979. V. 136. P. 555-558.
White L., Tursky В., Schwartz G. E. (Eds.) Placebo: Theory, research and mechanisms. N. Y.: Guilford Press, 1985.
What price psychotherapy? // Brit. Med. J. 1984. V. 288. No. 6420. P. 809-810.
Wickramasera I. A conditioned response model of the placebo effect: predictions from the model // Biofeedback and Self-Regulation. 1980. V. 5. P. 5-18.
Wilcox С S. et al. Predictors of placebo response: a retrospective analysis // Psychopharmacol. Bull. 1992. V. 28. No. 2. P. 157.
Wilkins W. Psychotherapy: the powerful placebo // J. of Consulting and Clinical Psychology. 1984. V. 52. P. 570-573.
Willemsen-Swlnkels S. H. N. et al. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. — Double-blind placebo-controlled studies // Arch. Gen. Psychiatry. 1995 V. 52. No. 9. P. 766-773.
Wolf S. The pharmacology of placebos // Pharmacol. Revs. 1959. V. 11. P. 689-704.
Working-Group. Minimum information for sensible use of self-prescribed medicines // Lancet. 1977. Nov. 12. P. 1017-1019.
Young M. A., Fogg L. F. Predicting response to treatment: Differentiating active-factor and non-specific effects // Statistics in Medicine. 1990. V. 9. P. 253-261.
Zajiceh G. A scientific framework for the placebo effect // Cancer J. 1997. V. 10. P. 236-237.
Zitrin C. M., Klein D. F., Woerner M. G. Treatment of agoraphobia with group exposure in vivo and imipramine // Archives Gen. Psychiatry. 1980. V. 37. P. 63-72.
Об авторе
223
ОБ АВТОРЕ
ИЗЯСЛАВ ПЕТРОВИЧ ЛАПИН — врач высшей категории, доктор медицинских наук, профессор, главный научный сотрудник Санкт-Петербургского научно-исследовательского психоневрологического института имени В. М. Бехтерева.
|
